Traws Pharma Inc Stock (TRAW) Forecast
The Traws Pharma Inc (TRAW) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $0.4475, representing a +98.89% increase from the current price of $0.225. The highest analyst price target is $0.6814, and the lowest is $0.2136.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month TRAW Price Target
Average 4.09 (+1,720% Upside)
Is Traws Pharma Inc (TRAW) A Buy Now?
Oscillators
Buy: 4 · Sell: 2 · Neutral: 1Summary: Buy
Moving Averages
Buy: 0 · Sell: 10 · Neutral: 0Summary: Sell
According to our latest analysis, TRAW could be considered a Strong Sell, with 17 technical analysis indicators signaling 4 Buy signals, 12 signaling Sell signals and 1 Neutral signals. This might not be a good time to consider opening new positions on TRAW, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 19.45 indicates that TRAW is oversold. This indicates that TRAW price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 7.94 indicates that TRAW is oversold. This indicates that TRAW price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 2.17 indicates that TRAW is oversold. This suggests that TRAW price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of 30.36 suggests an extremely strong trend in the market. Such high values are relatively rare and indicate a very robust directional movement.
- CCI (Commodity Channel Index): A CCI(14) value of -99.90 indicates that TRAW is still oversold but not to an extreme extent.
Long-term TRAW price forecast for 2026, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Traws Pharma Inc financial reports and earnings history, Traws Pharma Inc (TRAW) stock could reach $21.35 by 2030, $33.64 by 2040 and $126.05 by 2050. See the projected annual prices until 2050 of the Traws Pharma Inc stock below:
- Traws Pharma Inc (TRAW) is expected to reach an average price of $48.84 in 2035, with a high prediction of $50.46 and a low estimate of $0.7592. This indicates an +21,607% change from the last recorded price of $0.225.
- Traws Pharma Inc (TRAW) stock is projected to chart a bullish course in 2040, with an average price target of $7.02, representing an +3,020% change from its current level. The forecast ranges from a conservative $7.04 to a sky-high $33.64.
- Our analysts predict Traws Pharma Inc (TRAW) to change +17,649% by 2045, soaring from $39.95 to an average price of $39.94, potentially reaching $73.63. While $39.95 is the low estimate, the potential upside is significant.
- Traws Pharma Inc (TRAW) stock is expected to climb by 2050, reaching an average of $89.47, a +39,665% change from its current level. However, a wide range of estimates exists, with high and low targets of $126.05 and $89.66, respectively, highlighting the market's uncertainty.
Traws Pharma Inc Stock (TRAW) Year by Year Forecast
Traws Pharma Inc Stock (TRAW) Price Forecast for 2026
The predicted value for Traws Pharma Inc (TRAW) in 2026 is set at an average of $1.08. Estimates vary from a peak of $3.23 to a trough of $0.2136, indicating an +380.64% surge from the present price of $0.225.
Traws Pharma Inc Stock (TRAW) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Traws Pharma Inc (TRAW) is $6.35, with a high forecast of $8.28 and a low forecast of $1.05. This indicates an +2,724% increase from the last price of $0.225.
Traws Pharma Inc Stock (TRAW) Price Forecast for 2028
In 2028, Traws Pharma Inc (TRAW) is projected to reach an average price of $5.17, with a high projection of $8.45 and a low estimate of $2.61. This indicates an +2,199% rise from the last price of $0.225.
Traws Pharma Inc Stock (TRAW) Price Forecast for 2029
The 2029 price forecast for Traws Pharma Inc Stock (TRAW) is $6.53 on average, with a high prediction of $20.23 and a low estimate of $0.1073. This represents an +2,804% increase from the previous price of $0.225.
Traws Pharma Inc Stock (TRAW) Price Forecast for 2030
Traws Pharma Inc Stock (TRAW) is expected to reach an average price of $19.12 in 2030, with a high forecast of $21.35 and a low forecast of $14.81. This signifies an +8,397% surge from the last price of $0.225.
